Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
Authors
Keywords
Insomnia, Benzodiazepines (BZD), Benzodiazepine receptor agonists, Z-drugs, Prolonged-release (PR) melatonin, Addiction
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume 69, Issue 4, Pages 1-10
Publisher
Springer Nature
Online
2012-10-31
DOI
10.1007/s00228-012-1424-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Essentials of Polysomnography: A Training Guide and Reference for Sleep Technicians
- (2017) Joseph T. Daley et al. SLEEP
- Reimbursement Restriction and Moderate Decrease in Benzodiazepine Use in General Practice
- (2012) J. M. Hoebert et al. ANNALS OF FAMILY MEDICINE
- Zolpidem for insomnia
- (2012) David J Greenblatt et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effects of prolonged-release melatonin and zolpidem on postural stability in older adults
- (2012) Sarah Otmani et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Gaining insight into benzodiazepine prescribing in General Practice in France: a data-based study
- (2011) Sophia Rosman et al. BMC Family Practice
- Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database
- (2011) Francois Chavant et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database
- (2011) Dieter Kunz et al. EXPERT OPINION ON PHARMACOTHERAPY
- Risk of Fractures Requiring Hospitalization After an Initial Prescription for Zolpidem, Alprazolam, Lorazepam, or Diazepam in Older Adults
- (2011) William D. Finkle et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
- (2010) Alan G Wade et al. BMC Medicine
- Increased Risk of Hospitalization Related to Motor Vehicle Accidents Among People Taking Zolpidem: A Case–Crossover Study
- (2010) Yao-Hsu Yang et al. JOURNAL OF EPIDEMIOLOGY
- New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists
- (2010) Ruediger Hardeland Neuropsychiatric Disease and Treatment
- Benzodiazepines and Injurious Falls in Community Dwelling Elders
- (2009) Antoine Pariente et al. DRUGS & AGING
- Medication Use and Increased Risk of Falls in Hospitalized Elderly Patients
- (2009) Mounir Rhalimi et al. DRUGS & AGING
- The effect of prolonged-release melatonin on sleep measures and psychomotor performance in elderly patients with insomnia
- (2009) Remy Luthringer et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Benzodiazepines in epilepsy: pharmacology and pharmacokinetics
- (2008) J. Riss et al. ACTA NEUROLOGICA SCANDINAVICA
- Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers
- (2008) S. Otmani et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam
- (2008) Ingebjørg Gustavsen et al. SLEEP MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More